Suicide as an outcome for mental disorders. A meta-analysis.
E C Harris, B Barraclough
https://pubmed.ncbi.nlm.nih.gov/9229027Actively Recruiting
Led by University Hospital, Ghent · Updated on 2025-11-18
390
Participants Needed
12
Research Sites
34 weeks
Total Duration
Researchers are evaluating the Suicidal Crisis Intervention (SCI) as a new short-term treatment method for people after a suicidal crisis or suicide attempt. This study aims to determine if SCI can reduce suicidality and also explore its effect on related factors such as hopelessness, defeat, entrapment, and interpersonal needs. The SCI was developed to provide evidence-based care in Flanders, addressing the limited interventions currently available for this high-risk group. The study compares two groups: one receiving the SCI alongside their usual treatment, and the other receiving only their usual treatment. The SCI includes four sessions focusing on providing insight into suicidal crises, involving loved ones, creating a safety plan, and ensuring continuity of care. It emphasizes a structured, person-centered approach and aims to motivate participants toward specialized care. Participants will be followed for approximately 222 days after randomization. Researchers will assess changes in suicidality using the Beck Scale for Suicide Ideation at multiple points, along with secondary measures such as suicidal behavior, hopelessness, defeat, entrapment, isolation, follow-up care readiness, and treatment satisfaction. Assessments are conducted at baseline, 42 days, 132 days, and 222 days to monitor progress and outcomes throughout the study period.
CONDITIONS
Effectiveness of the Suicidal Crisis Intervention (SCI)
You may qualify if you...
You will not qualify if you...
Complete this quick 3-step screening to check your eligibility
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Approximately 6 weeks (42 days)
Participants receive the Suicidal Crisis Intervention (SCI), a short-term treatment consisting of 4 sessions that aims to provide tools for dealing with future suicidal crises, involving close relatives and focusing on continuity of care. Participants in the control group receive their usual treatment.
4 treatment sessions over the course of the intervention
Duration - Approximately 6 months (180 days)
Participants are followed after treatment to assess changes in suicidality, hopelessness, suicidal behavior, and other related outcomes, as well as treatment satisfaction.
2 follow-up visits at 132 days and 222 days after randomization
Total: 12 locations
1
Psychiatrisch Centrum Sint Amandus (incl. Mobiel Crisis Team)
Beernem, Belgium
Actively Recruiting
2
Medisch Centrum St. Jozef
Bilzen, Belgium
Actively Recruiting
3
Mobiel Crisis Team zorggroep Multiversum
Boechout, Belgium
Actively Recruiting
4
Openbaar Psychiatrisch Zorgcentrum Geel
Geel, Belgium
Actively Recruiting
5
UZ Gent
Ghent, Belgium, 9000
Actively Recruiting
6
AZ Groeninge (incl. Mobiel Crisis Team Kortrijk)
Kortrijk, Belgium
Actively Recruiting
7
Psychiatrisch Ziekenhuis Heilige Familie Kortrijk
Kortrijk, Belgium
Actively Recruiting
8
Psychiatrisch Centrum Ariadne
Lede, Belgium
Actively Recruiting
9
Openbaar Psychiatrisch Zorgcentrum Rekem
Rekem, Belgium
Actively Recruiting
10
Algemeen Ziekenhuis Glorieux
Ronse, Belgium
Actively Recruiting
11
Psychiatrisch Ziekenhuis Sint Lucia (incl. Mobiel Team Acute Zorgen)
Sint-Niklaas, Belgium
Actively Recruiting
12
Bethanië GGZ (incl. mobiel crisis team SARA Het Veer)
Zoersel, Belgium
Actively Recruiting
E
Eva De Jaegere, Msc
P
Pauline Stas, Msc
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
E C Harris, B Barraclough
https://pubmed.ncbi.nlm.nih.gov/9229027Keith Hawton, Daniel Zahl, Rosamund Weatherall
https://pubmed.ncbi.nlm.nih.gov/12777346Merete Nordentoft
https://pubmed.ncbi.nlm.nih.gov/21130823